Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir

Healthy Participant Clinical Trial

Official title:
A PHASE 1, OPEN-LABEL, FIXED SEQUENCE, 2-PERIOD CROSSOVER STUDY TO ESTIMATE THE EFFECT OF CARBAMAZEPINE ON THE PHARMACOKINETICS OF PF-07321332 BOOSTED WITH RITONAVIR IN HEALTHY PARTICIPANTS

Status Completed

Clinical Trial Summary

This is a drug-drug interaction study to assess the effects of a single dose of PF-07321332/ritonavir after multiple dose administrations of carbamazepine. Pharmacokinetic (PK) will be evaluated for PF-07321332 and ritonavir. Carbamazepine is being utilized as a cytochrome P450 3A4 (CYP3A4) inducer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Healthy Participant

Clinical Trial Details

NCT number	NCT04962230
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 1
Start date	July 15, 2021
Completion date	October 9, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05311865` - Transmission of Covid-19 During Clubbing Events in Closed Places	N/A
Recruiting	`NCT05520216` - Effect of Rib Cage and Spine Mobility on Maximum Breath-Hold Time
Active, not recruiting	`NCT04807465` - Different Modes of Universal Adhesive in Smokers and Non-Smokers	N/A
Completed	`NCT06087055` - Drug-Drug Interaction Study of Itraconazole With GST-HG171/Ritonavir in Healthy Participants	Phase 1
Completed	`NCT04962022` - Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants	Phase 1
Completed	`NCT05450549` - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL919 in Healthy Participants	Phase 1
Active, not recruiting	`NCT04814836` - Laser Etching Effect on Application Mode of Universal Adhesive	N/A